Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.
3.

Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.

Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A.

Lancet. 2012 Feb 18;379(9816):641-7. doi: 10.1016/S0140-6736(11)61750-9. Epub 2012 Jan 4. Erratum in: Lancet. 2012 Feb 18;379(9816):616.

4.

Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group.

Bodsworth NJ, Crooks RJ, Borelli S, Vejlsgaard G, Paavonen J, Worm AM, Uexkull N, Esmann J, Strand A, Ingamells AJ, Gibb A.

Genitourin Med. 1997 Apr;73(2):110-6.

5.

Valaciclovir: a review of its use in the management of herpes zoster.

Ormrod D, Goa K.

Drugs. 2000 Jun;59(6):1317-40. Review.

PMID:
10882165
6.

Valaciclovir: development, clinical utility and potential.

Patel R.

Expert Opin Investig Drugs. 1997 Feb;6(2):173-89.

PMID:
15989601
7.

Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.

Patel R, Bodsworth NJ, Woolley P, Peters B, Vejlsgaard G, Saari S, Gibb A, Robinson J.

Genitourin Med. 1997 Apr;73(2):105-9.

8.

Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.

Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ; International Valaciclovir HSV Study Group.

Int J STD AIDS. 2002 Jan;13(1):12-21.

PMID:
11802924
10.

[Valaciclovir].

Lebrun-Vignes B.

Ann Dermatol Venereol. 2002 May;129(5 Pt 1):708-15. Review. French.

PMID:
12124513
11.

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Wagstaff AJ, Faulds D, Goa KL.

Drugs. 1994 Jan;47(1):153-205. Review.

PMID:
7510619
12.

Valaciclovir: new indications. In genital herpes: simpler administration.

[No authors listed]

Prescrire Int. 1999 Feb;8(39):8-9.

PMID:
10557565
13.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003774. doi: 10.1002/14651858.CD003774.pub4. Review.

PMID:
23450543
14.

Valaciclovir versus aciclovir for the treatment of primary genital herpes simplex: a cost analysis.

Pinder M, Wright A.

Int J STD AIDS. 2015 Nov;26(13):971-3. doi: 10.1177/0956462414563628. Epub 2014 Dec 12.

PMID:
25505043
15.

Antiviral therapy of herpes simplex and varicella-zoster virus infections.

Wutzler P.

Intervirology. 1997;40(5-6):343-56. Review.

PMID:
9675639
16.

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.

Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA.

J Infect Dis. 1998 Jan;177(1):48-56.

PMID:
9419169
17.

Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.

Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.

Cochrane Database Syst Rev. 2014 Aug 3;(8):CD009036. doi: 10.1002/14651858.CD009036.pub2. Review.

PMID:
25086573
18.

Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.

Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006706. doi: 10.1002/14651858.CD006706.pub2. Review.

PMID:
19160295
19.

Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.

Simpson D, Lyseng-Williamson KA.

Drugs. 2006;66(18):2397-416. Review.

PMID:
17181386

Supplemental Content

Support Center